Snca targeted antisense oligonucleotides mediate progression of pathological deposition in alpha synuclein rodent transmission models of Parkinson's disease

被引：0
作者：
Cole, Tracy [2 ]
Paumier, Katrina [3 ]
Zhao, Hien [2 ]
Weihofen, Andreas [1 ]
Kordasiewicz, Holly [2 ]
Swayze, Eric [2 ]
机构：
[1] Biogen, Neurol Res, Cambridge, MA USA
[2] ISIS Pharmaceut, Neurosci Drug Discovery, 2280 Faraday Ave, Carlsbad, CA 92008 USA
[3] Michigan State, Translat Sci & Mol Med, Grand Rapids, MI USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.239
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Role of alpha-synuclein gene variations in progression of idiopathic Parkinson's disease
    Fabiola, D. M.
    Lucia, C.
    Gaia, O.
    Miryam, C.
    Luca, M.
    Giulio, R.
    Alessio, D. F.
    D'Alfonso, S.
    Pietro, C. Giacomo
    Giorgio, B.
    Roberto, C.
    Cristoforo, C.
    MOVEMENT DISORDERS, 2014, 29 : S51 - S51
  • [32] The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson's Disease
    Magistrelli, Luca
    Contaldi, Elena
    Comi, Cristoforo
    LIFE-BASEL, 2021, 11 (08):
  • [33] Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease
    Yang, Jiaolong
    Luo, Shilin
    Zhang, Jichun
    Yu, Ting
    Fu, Zhihui
    Zheng, Yongfa
    Xu, Ximing
    Liu, Chaoyang
    Fan, Mingxia
    Zhang, Zhentao
    NEUROBIOLOGY OF DISEASE, 2021, 148
  • [34] Enteric gliosis entailed by pathological alpha-synuclein in the duodenum of Parkinson's disease patients
    Sandre, M.
    Emmi, A.
    Seguella, L.
    Favetta, G.
    Russo, F. P.
    Campagnolo, M.
    Carecchio, M.
    Kovacs, G. G.
    Esposito, G.
    Bubacco, L.
    De Caro, R.
    Antonini, A.
    GLIA, 2023, 71 : E502 - E502
  • [35] An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression
    Yang, Li
    Stewart, Tessandra
    Shi, Min
    Pottiez, Gwenael
    Dator, Romel
    Wu, Rui
    Aro, Patrick
    Schuster, Robert J.
    Ginghina, Carmen
    Pan, Catherine
    Gao, Yuqian
    Qian, Weijun
    Zabetian, Cyrus P.
    Hu, Shu-Ching
    Quinn, Joseph F.
    Zhang, Jing
    PROTEOMICS CLINICAL APPLICATIONS, 2017, 11 (7-8)
  • [36] Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons
    Heman-Ackah, Sabrina M.
    Manzano, Raquel
    Hoozemans, Jeroen J. M.
    Scheper, Wiep
    Flynn, Rowan
    Haerty, Wilfried
    Cowley, Sally A.
    Bassett, Andrew R.
    Wood, Matthew J. A.
    HUMAN MOLECULAR GENETICS, 2017, 26 (22) : 4441 - 4450
  • [37] Genetic variants of SNCA, risk of Parkinson's disease and alpha-synuclein level in CD45+blood cells
    Kulabukhova, D.
    Garaeva, L. A.
    Emelyanov, A. K.
    Ulitina, A. S.
    Miliukhina, I. V.
    Yakimovskii, A. F.
    Timofeeva, A. A.
    Pchelina, S. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1032 - S1033
  • [38] Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
    Guo, Mengyuan
    Ji, Xunming
    Liu, Jia
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [39] Neuropathology of conditional alpha-synuclein transgenic mouse models of Parkinson's disease
    Nuber, S.
    Petrasch-Parwez, E.
    Winner, B.
    Winkler, J.
    von Hoersten, S.
    Teismann, P.
    Schulz, J. B.
    Neumann, M.
    Fendt, M.
    Gellerich, F. N.
    Riess, O.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S122 - S122
  • [40] Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
    Majbour, Nour K.
    Vaikath, Nishant N.
    Eusebi, Paolo
    Chiasserini, Davide
    Ardah, Mustafa
    Varghese, Shiji
    Haque, M. Emdadul
    Tokuda, Takahiko
    Auinger, Peggy
    Calabresi, Paolo
    Parnetti, Lucilla
    El-Agnaf, Omar M. A.
    MOVEMENT DISORDERS, 2016, 31 (10) : 1535 - 1542
12345